MANE Veradermics, Incorporated

Healthcare

$101.62-2.94%ClosedMarket Cap: $4.25B

As of 2026-05-25

Valuation

P/E (TTM)

—

PEG

—

P/B

9.68

P/S

0.00

EV/EBITDA

-70.00

DCF Value

$0.60

FCF Yield

-1.1%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-95.4%

ROA

-13.7%

ROIC

-15.0%

Income Statement

Periods shown are fiscal year quarters (may differ from calendar year)

Period	Revenue	Gross Margin	Operating Income	Net Income	EPS	Dividend
Q1 null	$0.00	NaN%	$-29.9M	$-27.2M	$—	—
Q4 null	$0.00	NaN%	$-23.0M	$-21.8M	$—	—
FY null	$0.00	NaN%	$-72.3M	$-70.0M	$—	—
Q4 null	$0.00	NaN%	$-6.0M	$-5.7M	$—	—
FY null	$0.00	NaN%	$-26.8M	$-26.5M	$—	—
FY null	$0.00	NaN%	$-17.3M	$-16.5M	$—	—